fda warning letters compounded semaglutide september 2025 Issues to Telehealth Companies for False Clai The FDA sent a warning

Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model

Accredited testing partner Identity, purity, and concentration confirmed by MZ Biolabs (Tucson, AZ), a US DEA-licensed analytical facility, via HPLC and mass-spectrometry identity confirmation under GLP standards

Curcumin nanoemulsion suppresses HPV oncogenes and inhibits cervical cancer progression: in vitro and in vivo study

For topical use, transient local reactions redness, stinging, burning, or itch are the expected category and are exactly what the ongoing Phase 2 trial is set up to measure (NCT07437586)

These carbohydrates dont get digested in the small intestine, but instead ferment in the large intestine to feed good gut bacteria